Identification of a Primary Metabolite of Ibogaine That Targets Serotonin Transporters and Elevates Serotonin
Mechanisms Preclinical landmark
AI-extracted · unverified · confirm at source
First identification of noribogaine (12-hydroxyibogamine) as ibogaine's primary metabolite; Kᵢ 40.7 nM at SERT (10-fold > ibogaine); 3-fold 5-HT elevation in nucleus accumbens; long half-life with 508–706 ng/ml at 24h post-dose
Sample size: 3